Search Results - "Marrone, J R"
-
1
Higher rates of streptococcal colonization among children in the Pacific Rim Region correlates with higher rates of group A streptococcal disease and sequelae
Published in Clinical microbiology and infection (01-05-2010)“…Group A streptococcal (GAS) pharyngeal colonization rates were determined among 1061 asymptomatic students in Hawaii and American Samoa where acute rheumatic…”
Get full text
Journal Article -
2
Entamoeba histolytica meningoencephalitis diagnosed by trophozoites in cerebrospinal fluid
Published in New microbes and new infections (01-10-2013)“…Abstract Entamoeba histolytica meningoencephalitis has not been described in the modern literature, which is distinct from that caused by free-living amoebae…”
Get full text
Journal Article -
3
Effects of U-37883A, a vascular selective KATP+ channel antagonist, in the pulmonary and hindlimb circulation
Published in The American journal of physiology (01-12-1996)“…The effects of the vascular selective nonsulfonylurea guanidine ATP-sensitive K+ (KATP+) channel-blocking agent U-37883A on vasodilator and vasoconstrictor…”
Get full text
Journal Article -
4
Differential effects of L-N5-(1-iminoethyl)-ornithine on tone and endothelium-dependent vasodilator responses
Published in The American journal of physiology (01-09-1997)“…The effects of the nitric oxide (NO) synthesis inhibitor L-N5-(1-iminoethyl)-ornithine (L-NIO) on baseline tone and on responses to the endothelium-dependent…”
Get full text
Journal Article -
5
Comparison of responses to novel nitric oxide donors in the feline pulmonary vascular bed
Published in European journal of pharmacology (02-11-2001)“…Pulmonary vascular responses to the novel diazeniumdiolate nitric oxide (NO) donors diethylamine/NO, diethylenetriamine/NO, spermine/NO, sulfite/NO, and…”
Get full text
Journal Article -
6
Comparison of responses to siguazodan, rolipram, and zaprinast in the feline pulmonary vascular bed
Published in European journal of pharmacology (13-10-2000)“…The present study was undertaken to investigate and compare responses to the cyclic nucleotide phosphodiesterase inhibitors siguazodan (type III, guanosine…”
Get full text
Journal Article